| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absorption, metabolism and excretion of [14C]-sotorasib in healthy male subjects: characterization of metabolites and a minor albumin-sotorasib conjugate
|
Vuu, Irene
|
|
|
90 |
4 |
p. 357-367
|
artikel
|
| 2 |
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics
|
Fudio, Salvador
|
|
|
90 |
4 |
p. 285-299
|
artikel
|
| 3 |
A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors
|
Massard, C.
|
|
|
90 |
4 |
p. 335-344
|
artikel
|
| 4 |
Effect of fluconazole on the pharmacokinetics of a single dose of fedratinib in healthy adults
|
Chen, Yizhe
|
|
|
90 |
4 |
p. 325-334
|
artikel
|
| 5 |
Model-informed approach for risk management of bleeding toxicities for bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1
|
Vugmeyster, Yulia
|
|
|
90 |
4 |
p. 369-379
|
artikel
|
| 6 |
Physiologically based pharmacokinetic modeling of ponatinib to describe drug–drug interactions in patients with cancer
|
Morita, Tomoko O.
|
|
|
90 |
4 |
p. 315-323
|
artikel
|
| 7 |
Population pharmacokinetics of cisplatin in small cell lung cancer patients guided with informative priors
|
Aguiar Zdovc, Jurij
|
|
|
90 |
4 |
p. 301-313
|
artikel
|
| 8 |
Potentiation of temozolomide activity against glioblastoma cells by aromatase inhibitor letrozole
|
Karve, Aniruddha S.
|
|
|
90 |
4 |
p. 345-356
|
artikel
|
Tijdschrift beschrijving